Date:11/04/2006 URL: http://www.thehindubusinessline.com/2006/04/11/stories/2006041102731500.htm

Back Solvay Pharma: Betting on vaccine

Strong performance of a new vaccine for influenza and talk of bonus issue are understood to be driving Solvay Pharma. Expectation of a large acquisition is also in the air.

The stock moved up by over five per cent to close at Rs 567 on the BSE.

Jayanta Mallick